McKesson Corporation (MCK) closed at $866.73 on September 26, 2026, declining 0.28% over the prior 24 hours. The move continued a broader pullback for the pharmaceutical distribution giant, which has now fallen 0.99% over the past seven days.
The 30-day performance tells a similar story, with MCK shedding 3.35% over that stretch. Despite the recent pressure, the company retains a market capitalization of $101.36 billion, keeping it among the largest firms in its sector.
Friday's session offered no relief for shareholders as the stock drifted lower without reversing any of the losses accumulated over the past several weeks. The gradual, measured pace of the decline reflects steady selling pressure rather than any sharp single-session move.
With the one-month loss now standing at 3.35%, MCK's near-term trend remains negative across all three tracked timeframes — daily, weekly, and monthly — marking a consistent pattern of softening for the distributor's shares heading into the final stretch of the month.
